Cargando…

Scapula chondrosarcoma: A case report

RATIONALE: Chondrosarcoma is a malignant mesenchymal tumor originating from cartilage. The pelvis, ribs, femur, and humerus are the most frequently affected sites, and scapula involvement is relatively rare. The aim of the present study was to report a case of chondrosarcoma in the scapula. PATIENT...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiang, Shuai, Ma, Xin-Nan, Wang, Hong-Wei, Lv, Song-Cen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831252/
https://www.ncbi.nlm.nih.gov/pubmed/31027132
http://dx.doi.org/10.1097/MD.0000000000015388
_version_ 1783465926057787392
author Qiang, Shuai
Ma, Xin-Nan
Wang, Hong-Wei
Lv, Song-Cen
author_facet Qiang, Shuai
Ma, Xin-Nan
Wang, Hong-Wei
Lv, Song-Cen
author_sort Qiang, Shuai
collection PubMed
description RATIONALE: Chondrosarcoma is a malignant mesenchymal tumor originating from cartilage. The pelvis, ribs, femur, and humerus are the most frequently affected sites, and scapula involvement is relatively rare. The aim of the present study was to report a case of chondrosarcoma in the scapula. PATIENT CONCERNS: A 42-year-old woman presented with a 3-month history of a painful mass in the right scapula. DIAGNOSES AND INTERVENTION: The patient underwent tumor resection. The post-operative pathological diagnosis was scapula chondrosarcoma. OUTCOMES: Following resection, the patient continued to receive routine follow-up care. There was no recurrence or tumor metastasis at a follow-up of 5 years. CONCLUSIONS: Surgery remains the primary therapy for chondrosarcoma. One of the greatest challenges in the management of chondrosarcoma is to accurately assess tumor grade before surgical intervention. Chemotherapy and radiotherapy have been applied without success. Chemo- and radioresistance have been examined beyond classic phenotypic properties to identify more efficient therapeutic strategies. Therefore, development of future novel therapies is contingent upon elucidating the molecular mechanisms of chondrosarcoma.
format Online
Article
Text
id pubmed-6831252
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-68312522019-11-19 Scapula chondrosarcoma: A case report Qiang, Shuai Ma, Xin-Nan Wang, Hong-Wei Lv, Song-Cen Medicine (Baltimore) 5700 RATIONALE: Chondrosarcoma is a malignant mesenchymal tumor originating from cartilage. The pelvis, ribs, femur, and humerus are the most frequently affected sites, and scapula involvement is relatively rare. The aim of the present study was to report a case of chondrosarcoma in the scapula. PATIENT CONCERNS: A 42-year-old woman presented with a 3-month history of a painful mass in the right scapula. DIAGNOSES AND INTERVENTION: The patient underwent tumor resection. The post-operative pathological diagnosis was scapula chondrosarcoma. OUTCOMES: Following resection, the patient continued to receive routine follow-up care. There was no recurrence or tumor metastasis at a follow-up of 5 years. CONCLUSIONS: Surgery remains the primary therapy for chondrosarcoma. One of the greatest challenges in the management of chondrosarcoma is to accurately assess tumor grade before surgical intervention. Chemotherapy and radiotherapy have been applied without success. Chemo- and radioresistance have been examined beyond classic phenotypic properties to identify more efficient therapeutic strategies. Therefore, development of future novel therapies is contingent upon elucidating the molecular mechanisms of chondrosarcoma. Wolters Kluwer Health 2019-04-26 /pmc/articles/PMC6831252/ /pubmed/31027132 http://dx.doi.org/10.1097/MD.0000000000015388 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 5700
Qiang, Shuai
Ma, Xin-Nan
Wang, Hong-Wei
Lv, Song-Cen
Scapula chondrosarcoma: A case report
title Scapula chondrosarcoma: A case report
title_full Scapula chondrosarcoma: A case report
title_fullStr Scapula chondrosarcoma: A case report
title_full_unstemmed Scapula chondrosarcoma: A case report
title_short Scapula chondrosarcoma: A case report
title_sort scapula chondrosarcoma: a case report
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831252/
https://www.ncbi.nlm.nih.gov/pubmed/31027132
http://dx.doi.org/10.1097/MD.0000000000015388
work_keys_str_mv AT qiangshuai scapulachondrosarcomaacasereport
AT maxinnan scapulachondrosarcomaacasereport
AT wanghongwei scapulachondrosarcomaacasereport
AT lvsongcen scapulachondrosarcomaacasereport